Upregulation of circ-AKT3 can inhibit the synthesis of fibrosis-associated protein through sponging miR-296-3p to modulate E-cadherin, which might provide a non-negligible potential opportunity for therapeutic targets of patients with DN (Tang et al., 2020b). This evidence concerns the gene AKT3 and liver dysplastic nodule.